Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model-Reference-Cited by-同舟云学术

Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model

Published:2020-11-02 Issue:4 Volume:303 Page:1099-1108
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Hortu Ismet^ORCID,Karadadas Elif,Ozceltik Gokay,Tavmergen Erol,Tavmergen Goker Ege Nazan,Yigitturk Gurkan,Erbas Oytun

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00404-020-05855-1.pdf

Reference38 articles.

1. Petrenko AP, Castelo-Branco C, Marshalov DV, Salov IA, Shifman EM (2019) Ovarian hyperstimulation syndrome. A new look at an old problem. Gynecol Endocrinol 35:651–656

2. Humaidan P, Nelson SM, Devroey P, Coddington CC, Schwartz LB, Gordon K et al (2016) Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials. Hum Reprod 31:1997–2004

3. Practice Committee of the American Society for Reproductive Medicine (2016) Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril 106:1634–1647

4. Zohav E, Almog B, Cohen A, Levin I, Deutsch V, Many A et al (2017) A New perspective on the risk of hypercoagulopathy in ovarian hyperstimulation syndrome using thromboelastography. Reprod Sci 24:1600–1606

5. Nastri CO, Teixeira DM, Moroni RM, Leitao VM, Martins WP (2015) Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention. Ultrasound Obstet Gynecol 45:377–393

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing New Prospects: Antipsychotic Drugs Exert Anti-Tumor Effects against Gastric Cancer through Inducing Apoptosis;Current Cancer Drug Targets;2024-07-09

2. Betaine Attenuates The Expression of Vasoactive Mediators and Histological Alterations Associated with Ovarian Hyperstimulation Syndrome in Rats;CELL J;2024

3. Vitamin D3 reduces the symptoms of ovarian hyperstimulation syndrome in mice and inhibits the release of granulosa cell angiogenic factor through pentraxin 3;In Vitro Cellular & Developmental Biology - Animal;2024-04

4. Efficacy of Dan’e Fukang Soft Extract in Moderate Ovarian Hyperstimulation Syndrome for Concurrent Treatment of Blood and Fluid Guided by the “Triple Prevention” Principle;International Journal of Women's Health;2024-03

5. Comparison of Steroidogenic and Ovulation-Inducing Effects of Orthosteric and Allosteric Agonists of Luteinizing Hormone/Chorionic Gonadotropin Receptor in Immature Female Rats;International Journal of Molecular Sciences;2023-11-22